Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,194 | 553 | 96.8% |
| Education | $301.17 | 6 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,940 | 190 | $0 (2024) |
| PFIZER INC. | $929.05 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $690.72 | 36 | $0 (2024) |
| Amgen Inc. | $673.24 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $558.36 | 37 | $0 (2022) |
| Astellas Pharma US Inc | $484.71 | 22 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $414.48 | 24 | $0 (2024) |
| Lilly USA, LLC | $404.20 | 28 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $266.74 | 16 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $243.45 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,239 | 41 | AstraZeneca Pharmaceuticals LP ($273.72) |
| 2023 | $1,062 | 38 | Novo Nordisk Inc ($190.72) |
| 2022 | $1,119 | 60 | Novo Nordisk Inc ($536.32) |
| 2021 | $1,127 | 73 | Novo Nordisk Inc ($352.70) |
| 2020 | $720.03 | 55 | Novo Nordisk Inc ($187.77) |
| 2019 | $1,493 | 97 | Novo Nordisk Inc ($533.53) |
| 2018 | $1,520 | 110 | Novo Nordisk Inc ($495.03) |
| 2017 | $1,215 | 85 | Novo Nordisk Inc ($414.52) |
All Payment Transactions
559 individual payment records from CMS Open Payments — Page 4 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/06/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: UROLOGY | ||||||
| 01/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 01/13/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 12/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: DIABETES | ||||||
| 11/29/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: UROLOGY | ||||||
| 11/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $105.26 | General |
| Category: Diabetes | ||||||
| 10/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: Diabetes | ||||||
| 10/20/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Diabetes | ||||||
| 10/20/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Diabetes | ||||||
| 10/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 10/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Cardio-renal | ||||||
| 10/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Diabetes | ||||||
| 09/23/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 09/13/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.41 | General |
| 09/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Cardio-renal | ||||||
| 08/31/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Bone Health | ||||||
| 08/30/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.69 | General |
| 08/29/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/10/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: DIABETES | ||||||
| 08/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 372 | 576 | $91,030 | $45,498 |
| 2022 | 16 | 714 | 1,014 | $119,919 | $42,844 |
| 2021 | 20 | 1,275 | 2,022 | $210,142 | $113,039 |
| 2020 | 22 | 1,540 | 2,511 | $247,391 | $111,899 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 244 | $30,140 | $16,353 | 54.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 121 | $22,685 | $11,820 | 52.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 62 | 62 | $14,260 | $7,860 | 55.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 36 | $7,020 | $3,475 | 49.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 43 | $6,540 | $2,759 | 42.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $4,750 | $2,014 | 42.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 19 | 20 | $3,870 | $902.26 | 23.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 16 | $640.00 | $174.39 | 27.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,125 | $140.76 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 167 | 348 | $41,420 | $16,652 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 142 | $20,402 | $7,584 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $20,260 | $4,900 | 24.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 41 | $7,995 | $3,402 | 42.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 39 | $5,850 | $2,264 | 38.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 20 | $5,000 | $2,204 | 44.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 29 | $2,406 | $1,149 | 47.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 28 | 30 | $3,872 | $931.82 | 24.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $3,660 | $794.33 | 21.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 24 | $920.00 | $719.93 | 78.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 21 | $2,730 | $669.27 | 24.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 31 | 41 | $1,495 | $389.75 | 26.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 104 | 124 | $1,345 | $367.62 | 27.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 15 | $621.00 | $314.67 | 50.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 14 | 14 | $938.00 | $296.79 | 31.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 22 | 23 | $1,005 | $204.78 | 20.4% |
About Dr. Mazen Alsaqa, M.D
Dr. Mazen Alsaqa, M.D is a Internal Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982968244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mazen Alsaqa, M.D has received a total of $9,495 in payments from pharmaceutical and medical device companies, with $1,239 received in 2024. These payments were reported across 559 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,194).
As a Medicare-enrolled provider, Alsaqa has provided services to 3,901 Medicare beneficiaries, totaling 6,123 services with total Medicare billing of $313,281. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Sterling Heights, MI
- Active Since 07/01/2012
- Last Updated 01/31/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982968244
Products in Payments
- Ozempic (Drug) $912.80
- Victoza (Drug) $684.50
- Rybelsus (Drug) $562.67
- XARELTO (Drug) $470.14
- FARXIGA (Drug) $374.75
- Tresiba (Drug) $332.20
- EVENITY (Biological) $313.90
- LYRICA (Drug) $297.77
- XIFAXAN (Drug) $270.13
- TRULICITY (Drug) $255.15
- TRADJENTA (Drug) $241.48
- AIRSUPRA (Drug) $229.47
- ELIQUIS (Drug) $216.56
- Aimovig (Biological) $198.97
- JARDIANCE (Drug) $193.21
- GEMTESA (Drug) $172.83
- CHANTIX (Drug) $164.30
- TOUJEO (Drug) $156.31
- RYBELSUS (Drug) $145.31
- Vascepa (Drug) $134.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sterling Heights
Dr. Syed Ali Muttaqi Husain, M.d, M.D
Internal Medicine — Payments: $54,045
Sandeep Garg, Md, MD
Internal Medicine — Payments: $37,573
Dr. Sami Asmar, M.d, M.D
Internal Medicine — Payments: $13,662
Dr. Zbigniew Purzycki, M.d, M.D
Internal Medicine — Payments: $12,572
Dr. Victor Al-Matchy, M.d, M.D
Internal Medicine — Payments: $12,259
Dr. Nicolas Marsheh, M.d, M.D
Internal Medicine — Payments: $10,498